Peripheral vascular malformations: Imaging, treatment approaches, and therapeutic issues

Radiographics

Volumn 25, Issue SPEC. ISS., 2005, Pages

  Hyodoh, Hideki ^a   Hori, Masakazu ^a   Akiba, Hidenari ^a   Tamakawa, Mitsuharu ^a   Hyodoh, Kazusa ^a   Hareyama, Masato ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; FEMALE; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL VASCULAR DISEASE;

ADOLESCENT; ADULT; ARTERIOVENOUS MALFORMATIONS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 28044461991     PISSN: 15271323     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.25si055509     Document Type: Conference Paper

References (41)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-422.
2. Jackson IT, Carreno R, Potparic Z, Hussain K. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 1993;91:1216-1230.
3. Enjolras O. Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol 1997;24:701-710.
4. Kawanabe T, Wakita S, Harii K, Hayashi N, Inoue Y. Sclerotherapy of hemangiomas and vascular malformations in lips. Jpn J Plast Reconstr Surg 1996;16:852-862.
5. Inoue Y, Wakita S, Yoshikawa K, et al. Evaluation of flow characteristics of soft-tissue vascular malformations using technetium-99m labelled red blood cells. Eur J Nucl Med 1999;26:367-372.
6. Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. RadioGraphics 2001;21:1519-1531.
7. Mulliken JB, Zetter BR, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery 1982;92:348-353.
8. Kaplan PA, Williams SM. Mucocutaneous and peripheral soft-tissue hemangiomas: MR imaging. Radiology 1987;163:163-166.
9. Boll DT, Merkle EM, Lewin JS. Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome. Radiology 2004;233:376-384.
10. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-351.
11. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-195.
12. Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osier-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 2003;79:18-24.
13. Vikkula M, Boon LM, Mulliken JB. Molecular genetics of vascular malformations. Matrix Biol 2001;20:327-335.
14. Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation- arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003;73:1240-1249.
15. Inoue Y, Ohtake T, Wakita S, et al. Flow characteristics of soft-tissue vascular anomalies evaluated by direct puncture scintigraphy. Eur J Nucl Med 1997;24:505-510.
16. Feoktistov I, Ryzhov S, Zhong H, et al. Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 2004;44:649-654.
17. Yakes WF, Haas DK, Parker SH, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology 1989;170:1059-1066.
18. Suh JS, Shin KH, Na JB, Won JY, Hahn SB. Venous malformations: sclerotherapy with a mixture of ethanol and lipiodol. Cardiovasc Intervent Radiol 1997;20:268-273.
19. Osuga K, Hori S, Kitayoshi H, et al. Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres. J Vasc Interv Radiol 2002;13:1125-1133.
20. Tan KT, Simons ME, Rajan DK, Terbrugge K. Peripheral high-flow arteriovenous vascular malformations: a single-center experience. J Vasc Interv Radiol 2004;15:1071-1080.
21. Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology 2002;223:639-644.
22. Lee BB, Kim DI, Huh S, et al. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg 2001;33:764-772.
23. Yakes WF, Luethke JM, Parker SH, et al. Ethanol embolization of vascular malformations. RadioGraphics 1990;10:787-796.
24. Yakes WF. Extremity venous malformations: diagnosis and management. Semin Interv Radiol 1994;11:332-339.
25. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999;104:1-11.
26. O'Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol 1997;169:723-729.
27. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 2003;37:533-538.
28. Yakes WF, Rossi P, Odink H. How I do it. Arteriovenous malformation management. Cardiovasc Intervent Radiol 1996;19:65-71.
29. Hammer FD, Boon LM, Mathurin P, Vanwijck RR. Ethanol sclerotherapy of venous malformations: evaluation of systemic ethanol contamination. J Vasc Interv Radiol 2001;12:595-600.
30. Hyodoh H, Fujita A, Hyodoh K, Furuse M, Kamisawa O, Hareyama M. High-flow arteriovenous malformation of the lower extremity: ethanolamine oleate sclerotherapy. Cardiovasc Intervent Radiol 2001;24:348-351.
31. Connor WE, Hoak JC, Warner ED. Massive thrombosis produced by fatty acid infusion. J Clin Invest 1963;42:860-866.
32. Sukigara M, Taguchi Y, Yamazaki T, Koga K, Miyamae T, Omoto R. Distribution of ethanolamine oleate after injection in esophageal varices. Nippon Geka Gakkai Zasshi 1984;85:1523-1527.
33. Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988;2:340-341.
34. Ohta M, Hashizume M, Ueno K, Tanoue K, Sugimachi K. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy. Hepatogastroenterology 1993;40:65-68.
35. Winter H, Drager E, Sterry W. Sclerotherapy for treatment of hemangiomas. Dermatol Surg 2000;26:105-108.
36. Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 2000;26:323-328.
37. Jain R, Bandhu S, Sawhney S, Mittal R. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound 2002;30:416-423.
38. Mimura H, Kanazawa S, Yasui K, et al. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy. Acta Med Okayama 2003;57:227-234.
39. Marrocco-Trischitta MM, Guerrini P, Abeni D, Stillo F. Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 2002;28:153-155.
40. Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyon WS. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 2004;39:590-600.
41. Kademani D, Costello BJ, Ditty D, Quinn P. An alternative approach to maxillofacial arteriovenous malformations with transosseous direct puncture embolization. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:701-706.